ANI Pharmaceuticals
ANIP
ANIP
28 hedge funds and large institutions have $10.6M invested in ANI Pharmaceuticals in 2013 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
20% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 10
36% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 14
Holders
28
Holding in Top 10
1
Calls
$4.47M
Puts
$446K
Top Buyers
| 1 | +$1.76M | |
| 2 | +$1.08M | |
| 3 | +$240K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$229K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$148K |
Top Sellers
| 1 | -$59K | |
| 2 | -$38K | |
| 3 | -$36K | |
| 4 |
Goldman Sachs
New York
|
-$33K |
| 5 |
U
UBS
Zurich,
Switzerland
|
-$30.8K |